REFERENCES

1. C.K. Kokate, A. P. Purohit, S.B. Gokhale., (2002) Pharmacognosy 13th

edition, Nirali Prakashan, Page. 1-14.

2. C.S. Shah, J.S. Quadry., (1995) Text Book of Pharmacognosy 11th

edition Page. 3.

3. Anonymous (1998) NBRI News Letter.

4. B. Dhar, K.V. Billore, O.P. Gupta., (2003) An evaluation of some

controversial Ayurvedic Drugs of Indian Pharmaceutical industry. Recent

Progress of Indian Medicinal plants 1st edition Vol. 1. Page. 307-309.

5. B.N. Dhavan., (2002) Prioritising Indian Flora for drug development, IDMA

Bulletin Vol. 33(6) Page. 140.

6. Pulok. K. Mukherjee., (2001) Quality control of Herbal Medicines, 1st

edition, Page.492-505.

7. Girish Dwivedi, Shridhar Dwivedi., (2007) History of Medicine: Sushruta –

the Clinician –Teacher par Excellence, National Informatics Centre, Page.

224-225.

8. Ernst E (2007). Herbal medicines: balancing benefits and risks. Novartis

Foundation Symposium, 282 Page. 154–67.

9. Huffman MA., (2003). Animal self-medication and ethno-medicine:

exploration and exploitation of the medicinal properties of plants.

Proceedings of Nutrition Society, 62 (2): 371–81.

10. Bruneton.J.,(1999). Pharmacognosy,Phytochemistry,Medicinal plants”

2nd Edition ; Lavoisier Publication France, Page. 12-30

11. Subramanian S., Sekhar.D.S. (2006) Hypolipidemic Effect Of Momordica

charantia seed extract on streptozotocin induced diabetic rats; J.Natural

remedies, 6(2) 41-52

12. Dandagi.P.M, Patil.M.B, Masthiholimath V.S, Gadg.A.P,

Dhumansure.R.H. (2008) Development and evaluation of

hepatoprotective polyherbal formulation containing some indigenous

medicinal plants , Indian Journal of pharmaceutical sciences. 26-268

13. Sikarwar, Mukesh Singh. (2011) Formulation and evaluation of some Indian

Medicinal plants for antidiabetic and Antihyperlipidemic activity. Diss. KLE

University, Belgaum, Karnatka, 2011. Page. 22-24

14. V.V. Sivarajan., Indira Balachandran., (1994) Ayurvedic Drugs and their

Plant Sources. Oxford and IBH Publishing Company. Page. 3-14.

15. F.Leena Tripathi and Jaindra Nath Tripathi., (2003) Role of biotechnology

in medicinal plants. Tropical Journal of Pharmaceutical Research, 2

(2):243-253.

16. S.J. Murch, S.Krishna Raj , P.K. Saxena.(2000) Tryptophan is a

precursor for melatonin and serotonin biosynthesis in in-vitro

regenerated St. John's wort (Hypericum perforatum L. CV. Anthos)

plants. Plant Cell Report. Vol. 19 Page. 698-704.

17. R.K. Issar.,S.S.Pant.,(1996) Bullettin of Medico-Ethnobotanical Research

Vol.17(1) Page. 1.

18. History as a tool in identifying new old drugs. (2002) Adv Exp Med Biol.

(505): 89– 94.

19. S. Chidambarathanu Pillai., (1992) Siddha System of Pharmacopoeia.

Siddha Medical Literature research Centre. Page 2-3.

20. Greenlee H (2012) Natural Products for Cancer Prevention. Semin Oncol

Nurs 28: 29-44.

21. Heinrich M (2010) Ethnopharmacology and Drug Discovery.

Comprehensive Natural Products II 3: 351-381.

22. Varro. E. Tyler, Lynn. E. Braddy, James. E. Robbere., (1991)

Pharmacognosy. Page. 17-23.

23. F.Leena Tripathi and Jaindra Nath Tripathi., (2003) Role of

biotechnology in medicinal plants Tropical Journal of Pharmaceutical

Research, Vol. 2 (2):243-253.

24. S.J. Murch, S.Krishna Raj , P.K. Saxena.(2000) Tryptophan is a

precursor for melatonin and serotonin biosynthesis in in-vitro

regenerated St. John's wort (Hypericum perforatum L. cv. Anthos) plants.

Plant Cell Report. Vol.19:698-704.

25. S.J. Murch, S.Krishna Raj , P.K. Saxena.(2000) Tryptophan is a

precursor for melatonin and serotonin biosynthesis in in-vitro

regenerated St. John's wort (Hypericum perforatum L. cv. Anthos) plants.

Plant Cell Rep. Vol. 19:698-704.

26. K.Y. Park K.J. Yu, S.I. Park, N.S. Sung, C.H. Park., (1995)

Micropropagation of Rehmannia glutinosa as medicinal plant by shoot tip

and root segment culture. Acta Horticult. Vol.39(1):113-120.

27. Blondeau S, Do QT, Scior T, Bernard P, Morin-Allory L. (2010) Reverse

pharmacognosy: another way to harness the generosity of nature.

Current Pharma Desertation 2010, 16(15):1682–1696.

28. Inic S, Kujundzic N(2011) The first independent pharmacognosy institute

in the world and its founder Julije Domac (1853–1928). Pharmazie 2011,

66(9):720–726.

226

226

29. Moattar F, Ghannadi A. (2011) Jorjani. General introduction. Journal of

Islamic Iranian Traditional Medicine, 1(4):397–402.

30. Shinde V, Dhalwal K, Mahadik KR. (2008) Some issue related to

pharmacognosy. Pharmacognosy Review, 2(3):1–5

31. Mahnaz Kazemi1 , Azadeh Eshraghi , Afsaneh Yegdaneh and Alireza

Ghannad. (2012) DARU Journal of Pharmaceutical Sciences,20:18

32. Jenkins N. (2010) Clinical pharmacy: evidence, ethics and medication

management in older people. Australian Jouranal of Pharmacy91(10):92–

95.

33. National cholesterol education program. (1994) Second report of the

expert panel on detection, evaluation and treatment of high blood

cholesterol in adults. Page.1333-1445.

34. Richard J P Cannel. (1998) Natural Product isolation. Human Press

Totowa, New Jersy. Page1-14.

35. Kishor Jain S, Kathivarin MK, Rahul S, Chamanal J. (2007)The biology

and chemistry of hyperlipidemia.Bioorganic And Medicinal Chemistry,15:4

674-4699.

36. Zalba G, San JG, Moreno MU, Fortuno A, Beaumont FJ, Diez J. (2001),

Role of NADPH oxidase. Hypertension, 38: 1395–1399.

37. Huynh Ngoc T, Nguyen Ngoc Q, Tran T Van A,Vo Phung N. (2008)

Hypolipidemic Effect of Extracts from Abelmoschus esculentus L.

(Malvaceae) on Tyloxapol-Induced Hyperlipidemia in Mice: Mahidol

University. Journal of Pharmaceutical Sciences, 35(1-4):42-46.

38. Bhatnagar D, Soran H, Durrington PN. (2008) Hypercholesterolaemia

and its management. British Medical Journal, 33(7):993.

227

227

39. Grundy SM, Balady GJ, Criqui MH. (1998) Primary prevention of coronary

heart disease: guidance from Framingham: a statement for healthcare

professionals from the AHA Task Force on Risk Reduction. American

Heart Association. Circulation, 97(18):1876–87.

40. Keane WF, Peter J, Kasiske BL. (1992) Is the aggressive management of

hyperlipidemia in nephrotic syndrome mandatory. Kidney International,

(suppl 38), S134-41.

41. Hopkins PN. (2003) Coronary artery disease risk in familial combined

hyperlipidemia and familial hypertriglyceridemia: a case-control

comparison from the National Heart, Lung, and Blood Institute Family

Heart Study. Circulation, 108:519-523.

42. K.Harikumar, S. Abdul Althaf, B. Kishore kumar, M. Ramunaik, CH.

Suvarna.(2013) A Review on Hyperlipidemic . International journal of

novel trends in Pharmaceutical Sciences,3(4):59-71.

43. Ford ES, Giles WH, Dietz WH. (2002) Prevalence of the metabolic

syndrome among US adults: findings from the third national health and

nutrition examination survey. JAMA, 287:356-359.

44. Jap TS, Jenq SF, Wu YC, Chiu CY, Cheng HM. (2003) Mutations in the

lipoprotein lipase gene as a cause of hypertriglyceridemia and

pancreatitis in Taiwan. Pancreas, 27:122-126.

45. Ylitalo K. (2002) LDL particle size in familial combined hyperlipidemia:

effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer

proteins. Journal of. Lipid Research 43:598-603.

46. Chiba H. (2003) Two cases with transient lipoprotein lipase (LPL) activity

impairment: evidence for the possible involvement of an LPL inhibitor.

European Journal of. Pediatrics,162:132-138.

228

228

47. Lipman TH, Hayman LL, Fabian CV, DiFazio DA, Hale PM, Goldsmith

BM. (2000) Risk factors for cardiovascular disease in children with type I

diabetes. Nursing Research,49(3):160-166.

48. Genest J, Libby P. (2011) Lipoprotein disorders and cardiovascular

disease. Braunwald's Heart Disease: A Textbook of Cardiovascular

Medicine; 9th ed. Philadelphia, PA Saunders, Elsevier,Page. 47.

49. Ray KK, Seshasai SR, Erqou S. (2010) Statins and all-cause mortality in

high-risk primary prevention: a meta analysis of 11 randomized

controlled trials involving 65,229 participants. Achieves of Internal

Medicine, 170(12): 1024–31.

50. Abourbih S, Filion KB, Joseph L, Schiffrin EL, Rinfret S, Poirier P, Pilote

L, Genest J, Eisenberg MJ. Effect of fibrates on lipid profiles and

cardiovascular outcomes: a systematic review. Am J Med, 2009,

122(10), 962.e1–962.

51. Wong NN. Colesevelam (2001) A new bile acid sequestrant. Heart

disease, 3(1): 63–70.

52. Bhatt. (2010) Effects of antioxidant vitamins along with atorvastatin and

atorvastatin–niacin combination on diet-induced hypercholesterolemia in

rats. International Journal of Physiology Pathophysiology and

Pharmacology, 2(1):57-63.

53. Ghani A. (2003) Medicinal Plants of Bangladesh with Chemical

Constituents and Uses. 2nd ed. Dhaka, Asiatic Society of

Bangladesh.Page. 10.

229

229

54. Dr. Nandkarni KM. (1976) Indian Materia Medica. Mumbai: Bombay

Popular Prakashan. 1: 165-6.

55. Warrier PK, Nair RV. (2002) Indian Medicinal plants: A compendium of

500 species, Madras: Orient Longman. Page. 224

56. Thomas S, Patil DA, Patil A .Gand Narseh Chandra. (2008)

Pharmacognostic evalution & physiochemical analysis of A.C L. fruit.

Journal of Herbal medicine & Toxicology, 2(2): 51-54

57. Sheth A, K Ashok. (2005) The Herbs of Ayurveda. Sheth publisher,

Herbal Medicine Research Centre, Institute for Medical Research,

Kualalampur. Compendium of Medicinal Plants used in Malaysia,1:92.

58. Anitha Roy, Geetha RV, Lakshmi T. (2011) Averrhoa bilimbi Linn– Nature’s Drug Store- A Pharmacological Review, International Journal of

Drug Development & Research, 3(3)75-79

59. Kamrul Islam Siddique. (2013) Phytochemical screenings, thrombolytic

activity and antimicrobial properties of the bark extracts of Averrhoa

bilimbi, Journal of Applied Pharmaceutical Science,3(03):094-096.

60. K. Ashok Kumar, SK. Gousia, Anupama, M. And J. Naveena Lavanya

Latha. (2013) A Review On Phytochemical Constituents And Biological

Assays Of Averrhoa Bilimbi. International Journal of Pharmacy and

Pharmaceutical Science Research 2013; 3(4): 136-139

61. Qingwei Wen, Xing Lin, Yeqi Liu, XiaohuiXu, Tao Liang, Ni Zheng,

KintokoKintoko and Renbin Huang. (2012), Phenolic and Lignan

Glycosides from the Butanol Extract of Averrhoacarambola L. Root.

Molecules, 17: 12330-12340.

62. A K. Azeem, Molly Mathew, Chandramohan Nair, Dilip C. (2010),

Hepatoprotective effect of Averrhoacarambola fruit extract on carbon

230

230

tetrachloride induced hepatotoxicity in mice. Asia pacific journal of

Tropical medicine, 3(8): 412-420.

63. Pal R. and Sarkar T. (2014), Visible Light Induced Knoevenagel

Condensation Catalyzed by Starfruit Juice of Averrhoacarambola.

International Journal of Organic Chemistry,4:106-115.

64. L.C.A. Gunasekara, P.H.P. Fernando and R. Sivakanesan. (2011), A

Preliminary Study on the Hypoglycaemic Effect of Averrhoacarambola

(Star Fruit) in Rats. Proceedings of the Peradeniya University Research

Sessions, Sri Lanka,16: 24.

65. BiswaNath Das and Muniruddin Ahmed. (2012), Analgesic activity of the

fruit extract of Averrhoacarambola. International journal of Life Sciences

Biotechnology and Pharma Research, 1(3): 1-4.

66. SayaliNapahde, Annika Durve, D.Bharati and Naresh Chandra.

(2010),Wine Production from Carambola Juice Using Averrhoacarambola

Saccharomyces cerevisiae. Asian Journal of.Experimental Biological

Sciences.Spl.10: 20-23

67. Chin-Tung Chang, M.D., Yung-Chang Chen, M.D., Ji-Tseng Fang, M.D.

and Chiu-Ching Huang., M.D. (2002), Star Fruit ( Averrhoacarambola)

intoxication: An important cause of consciousness disturbance in patients

with renal failure. Renal failure, 24(3): 379–382.

68. Yin Sze Lim and Shi Ting Lee. (2013), In vitro Antioxidant Capacities of

Star Fruit (Averrhoacarambola ), an Underutilised Tropical Fruit. Journal

of Biology,1(1): 21- 24.

69. Narain N., Bora, P S., Holschuh H J. Vasconcelos M. A. Da S. (2013),

Physical and chemical composition of CarambolaFruit

231

231

(Averrhoacarambola L.) at three stages of maturity.Cienc. Tecnol.

Aliment,3(3): 144-148.

70. Daniela Almeida Cabrini, Henrique Hunger Moresco, PriscilaImazu,

CıntiaDelai da Silva, EveliseFernandesPietrovski, Daniel Augusto

GasparinBueno Mendes,

Arthur da SilveiraPrudente, Moacir Geraldo Pizzolatti, Ines Maria Costa Bri

ghentand Michel FleithOtuki. (2011), Analysis of the Potential Topical Anti-

Inflammatory Activity of Averrhoacarambola L. in Mice. Evidence-Based

Complementary and Alternative Medicine, 2011:1-7.

71. Avinash G. Patil, Darshana A. Patil, Anita V. Phatak and Naresh Chandra.

(2010), Physical and chemical characteristics of Carambola

(Averrhoacarambola L) fruit at three stages of maturity. International

Journal of Applied Biology and Pharmaceutical Technology, 2(1): 624-629.

72. Suman das. (2012), Antimicrobial and Antioxidant activities of green and

ripe fruits of Averrhoacarambola Linn. And Zizyphusmauritiana Lam.

Asian Journal of Pharmaceutical and Clinical Research, 5(3): 102-105.

73. GheewalaPayal, KalariaPankti, ChakrabortyManodeep, KamathJagadish

V. (2012), Phytochemical and pharmacological profile of

Averrhoacarambola Linn: An overview. International Research Journal Of

Pharmacy, 3 (1): 88- 92.

74. Luisa Helena Cazarolli, VirgíniaDemarchiKappel, Danielle Fontana

Pereira, Henrique Hunger Moresco, Ines Maria Costa Brighente, Moacir

Geraldo Pizzolatti, Fatima Regina Mena Barreto Silva (2012). Anti-

hyperglycemic action of apigenin-6-C-β-fucopyranoside from

Averrhoacarambola. Fitoterapia, 8( October 2012): 1176–1183.

75. Shih-Wen Hung, MD; AmingChor-Ming Lin, MD; Chee-Fah Chong, MD;

Tzong-Luen Wang, MD, PhD; Hon-Ping Ma, MD Fatal Outcome after Star

232

232

Fruit (AverrhoaCarambola) Ingestion in Patient with Chronic Renal

Insufficiency. (2004), Ann Disaster Med,3(1): 56- 59.

76. Simone T. Goncalves, SilmaraBaroni, Fernando A. Bersani-Amado,

GessildaA.N. Melo, Diogenes A.G. Cortez, Ciomar A. Bersani-Amado and

Roberto K.N. Cuman. (2006), Preliminary Studies on Gastric Anti-

ulcerogenic Effects of Averrhoacarambola in Rats. Acta Farm.

Bonaerense, 25(2): 245-7

77. Md. Masum Mia, Mohammad S. Rahman, Kohinur Begum, Bilkis Begum

and Mohammad A. Rashid. (2007), Phytochemical and Biological Studies

of Averrhoacarambola. Dhaka University Journal of Pharmaceutical.

Science,6(2): 125-128.

78. Vera Lucia arroxelasgalvao de lima, Enayde de almeidamelo, Lueci dos

santos lima. (2011), Physicochemical characteristics of Bilimbi

(averrhoabilimbi l.). Rev. Bras. Frutic.,Jaboticabal, 23(2): 421-423.

79. Gloria D. Masilungan and Wella L. Absulio. (2012), Fruits of Bilimbi

(Averrhoabilimbi L.) as a New Natural Source of Ethylene for

Ripening of ‘Saba’ Banana (Musa balbisiana BBB). Philipp Agric Scientist,

95(4): 406–410.

80. P Dasgupta, P Chakraborty, N N. Bala. (2013), AverrhoaCarambola: An

Updated Review International Journal of Pharma Research & Review,2(7):

54-63.

81. PatilAvinash, KoliSwapneel, PatilDarshana and Phatak Anita. (2012), A

Comprehensive Review of An Important Medicinal Plant –

Averrhoacarambola L. Pharmacognosy Communications, 2(2): 13-17.

82. A K. Azeem, ArunRasheed, C. Dilip, Prasanth S S, Shebina P Rasheed

and Tina Thomas. (2013), Invitro anthelminthic activity of

233

233

Averrhoacarambolaleaf extracts. Journal of chemical and Pharmaceutical

Research,5(1): 296-298.

83. Anitha Roy , Geetha R V, Lakshmi T. (2011), Averrhoabilimbi Linn– Nature’s Drug Store- A Pharmacological Review. International Journal of

Drug Development & Research, 3(3):101-106.

84. K. Ashok Kumar, S K .Gousia, Anupama M. And J.

NaveenaLavanyaLatha. (2013), A review on phytochemical constituents

and biological assays of Averrhoabilimbi. International Journal of

Pharmacy and Pharmaceutical Science Research,3(4): 136-139.

85. Md. Ramjan Ali, MarjanHossain, JannatulFerdousRuna, Md.

Hasanuzzaman. (2013), Preliminary cytotoxic activity of different extracts

of Averrhoabilimbi (fruits). International Current Pharmaceutical Journal,

2(3): 83-84.

86. Sabiha Sultana Chowdhury, GolamMezbahUddin, NaziaMumtahana,

MokarramHossain and S.M. RaquibulHasan. (2012), In vitro antioxidant

and cytotoxic potential of hydromethanolic extract of Averrhoabilimbi L.

fruits. International Journal of Pharmaceutical Science and Research,3(7):

2263-2268.

87. Md. Hasanuzzaman, Md. Ramjan Ali, MarjanHossain, SourovKuri,

Mohammad Safiqul Islam. (2013), Evaluation of total phenolic content,

free radical scavenging activity and phytochemical screening of different

extracts of Averrhoabilimbi fruits. International Current Pharmaceutical

Journal, 2(4):92-961.

88. P. Pushparaj, C H. Tan, B K H. Tan. (2000), Effects of Averrhoabilimbi leaf

extract on blood glucose and lipids in streptozotocin-diabetic rats. Journal

of Ethnopharmacology, 72 (2000): 69 – 76.

234

234

89. V. N. Ariharan, K. Kalirajan, V. N. Meena Devi and P. Nagendra Prasad.

(2012) An Exotic Fruit Which Forms The New Natural Source For

Vitamin-C. Rasayan Journal of Chemistry, 5(3): 356-359.

90. Farah Amna Othman, NooraainHashim, Noriham Abdullah, Azizah Abdul

Hamid, MohamadFaiz Fong Abdullah , ZainonMohd Noor, Normah Ismail,

Wan RozianoorMohd Hassan, NurulHusnaRosli. (2014), Toxicity

evaluation of A. bilimbiLinn fruit extract on Haematological and

Histopathological evaluation in animal model. International journal of

Pharmaceutical science Review and Research,26(2): 39-43.

91. Nurul Hanani Mohamad Zaki, Halimahton Zahrah Mohamed Som ,

Zaibunnisa Abdul Haiyee. (2012) Application Of Palm Stearin

Chitosan Edible Coating On Star Fruits (Averrhoa carambola L.) The

Malaysian Journal of Analytical Sciences,16(3): 325 – 334

92. Soumya S L. and Bindu R Nair. (2014), Changes in the biochemical profile

of fruits of two species of Averrhoaduring development. International

journal of Pharmavy and Pharmaceutical Sciences,6(4): 572-577.

93. Mahanom H. ,Azizah A H and Dzulkifly MH. (1999), Effect of different

drying methods on concentrations of several phytochemicals in herbal

preparation of 8 medicinal plants leaves. Malasyian Journal of Nutrition, 5:

47-54.

94. K. Monalisa, M. Z. Islam, S. M. Asif-Ul-Alam, M. M. Hoque (2014)

Valorization and Storage Stability Assessment of Underutilized Fruit

Carambola (Averrhoa carambola) in Bangladesh. American Journal of

Food Science and Technology, 2(4): 134-138

95. Erasmo Herman Lara, Jesus Rodriguez Miranda, Juan G.Torruco

Uco, Roselis CarmonaGarcia, Patricia G. Mendoza Garcia, Hugo S.

Garcia, Ida Soto- Rodriguez, Enrique Sanchez Valdivieso, and Cecilia E.

235

235

Martinez-Sánchez. (2014) Impact of micronized star fruit (Averrhoa

carambola L.) fiber concentrate on lipid metabolism in mice. International

journal of food science and nutrition, 65(7): 862-867.

96. MohdRazi Ismail, KhuzaimahMohd Noor. (1996), Growth, water relations

and physiological processes of starfruit (Averrhoacarambola L) plants

under root growth restriction.Scientia horticulturae,66(12): 51-58.

97. M. Khalekuzzaman, M.F Alam, M Nuruzzaman, N Begum, M G Ahmed, M

A Islam, O.I.Jordar. (2003).Clonal propagation of Averrhoa carambola

Linn. Through nodal culture of mature tree. Journal of Biological

Sciences,3(12): 1153-1157.

98. Mandar Medhi. (2014). Eco-friendly synthesis of Silver Nanoparticles

Using Fruit extract of Averrhoa carambola. International Journal of

Innovative Science, Engineering & Technology,1(4):479-482.

99. Md. Al Nayem Chowdhury, M. Ashrafuzzaman, Md. Hazrat Ali, Lutfun

Nahar Liza, Kazi Mohammad Ali Zinnah. (2013) Antimicrobial

Activity of Some Medicinal Plants against Multi Drug Resistant

Human Pathogens. Advances in Bioscience and

Bioengineering,1(1):1-24.

100. Joysree Das , Zulon Datta, Ayan Saha, Suza Mohammad Nur, Prosenjit

Barua, Md. Mominur Rahman, Kazi Ashfak Ahmed Chowdhury,

Mohammad Mostofa Chowdhury, Rabiul Hossain Chowdhury, Adnan

Mannan (2013). A comprehensive study on antioxidant, antibacterial,

cytotoxic and phytochemical properties of averrhoa carambola.

International. Journal of Bioassays, 02(05): 803-807.

236

236

101. C.K. Ngan, A.M. Khairatul and S. Mohammad Shahid. (2012)

Determination of proposed maximum residue limit of cypermethrin in

starfruit (Averrhoa carambola) Journal of Tropical Agriculture and Food

Science. 40(1): 99– 106.

102. Avinash G. Patil, Darshana A. Patil, Abhishek J. Sharma and Naresh

Chandra. (2011), Comparative in Vitro Antioxidant Activity and HPTLC

Fingerprint of Averrhoabilmbi Linn. andAverrhoacarambola Linn. Fruit

Extracts. Asian Journal of Experimental Science, 25(1): 93-102.

103. Chien-Liang Chen, Kang-Ju Chou, Jyh-Seng Wang, Jeng-Hsien Yeh,

Hua-Chang Fang, and Hsiao-Min Chung. (2002) Neurotoxic Effects Of

Carambola In Rats: The Role Of Oxalate. Journal of Formosa Medical

Association, 101:337–341.

104. S.B Badgujar and M.B Patil. (2008) Ethnomedicines for jaundice used in

tribal areas of Nrth Maharashtra. Natural Products radiance, 7(1):79-81.

105. Shejuty Shahreen, Joyanta Banik, Abdul Hafiz, Shahnaz Rahman,

Anahita Tanzia Zaman, Md. Abu Shoyeb, Majeedul H. Chowdhury,

Mohammed Rahmatullah. (2012) Antihyperglycemic Activities Of Leaves

Of Three Edible Fruit Plants (Averrhoa Carambola, Ficus Hispida And

Syzygium Samarangense) Of Bangladesh. African Journal of Traditional

Complementary and Alternative Medicine,9(2):287-291.

106. Sumitra Chanda, Dilip Bhayani and Dishant Desai (2013) polyphenols

and flavonoids of twelve indian medicinal plants. The Bioscan 8(2): 595-

601.

107. B Jyothi, S. Mohana lakshmi, K. Anitha. (2013) Evaluation of

hepatoprotective effect of Averrhoa carambola L. leaves on anti-

tubercular drugs induced hepato- toxicity. International Journal of

Pharmaceutical Research and Development, 5(3):302-309.

237

237

108. Nguyen Phuoc Minh. (2014) Utilization of ripen star fruit for vinegar

ferment- ation. International Journal of Multidisciplinary Research and

Development; 1(4): 82-93.

109. Jyoti Bala Chauhan, Wethroe Kapfo , Gulnaz AR. (2015) In vitro

comparative study of Bilimbi and Star fruit extracts for Anthelmintic

activity. Discovery Biotechnology, 6(15): 5-8

110. Sreeja Nair, Jacob George, Sajeev Kumar, and Noble Gracious (2014)

Acute Oxalate Nephropathy following Ingestion of Averrhoa bilimbi Juice.

Case Reports in Nephrology Volume 2014, Article ID 240936, 5 pages.

111. Aklima, J., Mojumder, S. and Sikdar, D. (2014) Total phenolic content,

reducing power, antioxidative and anti-amylase activities of five

Bangladeshi fruits. International Food Research Journal, 21(1): 119-124.

112. M. C. Z Hassan , N. A. B. Ramli (2014). Production of acetic acid from

bilimbi (averrhoa bilimbi) using culture medium. 2 nd International

Congress on Food Technology; November 05-07, Turkey Association of

Food Technology & Ankara University, Turkey P.207.

113. Kitti Bodhipadmaa, Sompoch Noichindaa , Noppavan Chanunpanichb ,

Pornporm Thongmeethipa , Pussadee Chalermwanitkula , David W.M.

Leungc. (2011) Differential response of callus initiation and growth of

aromatic chilli and bilimbi to two different electrospun nanofibre mats,

ScienceAsia 37 : 303–307.

114. Marsudin Silalahi, S. Sinaga and P.T. Sihombing. (2012) Effect of Wuluh

star fruit juice (Averrhoa bilimbi) on fat digestibility, protein efficiency ratio

and rate of feed in pig’s digest system Proceedings of International

Conference on Livestock Production and Veterinary Technology

2012:199-203.

238

238

115. Gunawan, Arlene Cordero and Anamy Paano1,(2013) Structure

Elucidation Of Two New Phytol Derivatives, A New Phenolic Compound

And Other Metabolites Of Averrhoa Bilimbi. Proceedings of the Research

Congress 2013 De La Salle University Manila March 7-9. FNH-I-008.

116. Nurul Najidah Mohamed , Lai Sin Yuan , Lee Siew Ling , Ho Chin Siong ,

Sheela Chandren , Hadi Nur.(2014) Preparation of Hierarchical Porous

Carbon Derived from Averrhoa Bilimbi and Its Diffusion Properties. Jurnal

Teknologi (Sciences & Engineering) 69(5):61–64.

117. Bhaurav. T. Dangat, Anuja .A. Shinde, Dipali N. Jagtap, Varsharani R.

Desai, Prachi B. Shinde, and Rajaram. V. Gurav. (2014) Mineral Analysis

of Averrhoa bilimbi L. – a potential fruit. Asian Journal of Pharmaceutical

and Clinical Research,7(3):150-151.

118. Precious Love A. Agena, Coren Jane P. Albay, Celestine L. Apusen,

Mary Rose M. Arago, Janina Camille E. Catapang & Rheinmark Lloyd S.

Siapco. (2012) Topical administration of Averrhoa bilimbi Linn. Leaves

crude extract prevents UVB-induced oxidative damage in albino mice.

The seventh Volume, 6:29-41.

119. Thamizh Selvam N., Santhi P. S., Sanjayakumar Y. R., Venugopalan T.

N., Vasanthakumar K. G. and Swamy G. K. (2015) Hepatoprotective

activity of Averrhoa bilimbi fruit in acetaminophen induced hepatotoxicity

in wistar albino rats. Journal of Chemical and Pharmaceutical

Research,7(1):535-540.

120. Cut Fauziah , Sri Fitriyani, Viona Diansari (2012). Colour Change of

Enamel after Application of Averrhoa bilimbi. Journal of Dentistry

Indonesia,19(3) 53- 56.

239

239

121. Manish Gunjan, Liswaria Karna, Kosheelah Dayalan ,Puvaneswaran

Sasigaran (2012) A Review and Search of Phytomedicine Used by

Traditional People of Malaysia (Ipoh, Perak). International Journal Of

Phytothearpy Research, 2(3):26- 41.

122. Aprilita Rinayanti, Hikmah , Rasi Bangun and Sri Teguh Rahayu. (2013)

Effect Of Ethanol Extract Starfruit leaves (Averrhoa bilimbi L.) in inhibit

renal calcium stone formation in in rat. International Journal of Pharmacy

Teaching & Practices 4(2):546

123. Rassami. W and Soonwera M,(2013) invitro pedicullisidal activity of

herbal shampoo base on Thai local plants against head louse (Pediculus

humanus capitus de Geer). Parasitology Research, 112(4):1411-1416.

124. S. L. Soumya & Bindu R. Nair (2013) Floral morphological features and

variability in two species of Averrhoa L. (Oxalidaceae). The International

Journal of Plant Reproductive Biology 5(2):200-209.

125. K. Girija and L Lakshmanan (2011)Anti- hyperlipidemic activity of

methanolic extracts of three plants of Amaranthus in Triton WR 1339

induced hyperlipidemic rats. Asian Pacific Journal of Tropical

Biomedicine 2011:S62- S65.

126. Varsha Dhulasavant, Shubhangi Shinde, Mangesh Pawar, N.S. Naikwade

(2010) Antihyperlipidemic Activity of Cinnamomum tamala Nees. on High

Cholesterol Diet Induced Hyperlipidemia. International Journal of

PharmTech Research2(4):2517-2521.

127. Ahmad Movahedian,I Behzad Zolfaghari,II S.Ebrahim Sajjadi, II Reza

MoknatjouI (2010) Antihyperlipidemic effect of Peucedanum

pastinacifolium extract in streptozotocin induced diabetic rats.

Clinics,65(6):629-633.

240

240

128. Anonymous (2001). The Ayurvedic Pharmacopoeia of India. Vol.1.

Part.1. Page. 56-57.

129. Anonymous (1996). The Indian Pharmacopoeia. Vol.2. Page. A-53, A-70.

130. Madhu. C. Diwakar (2002) Plant Drug evaluation. Page. 57.

131. Anonymous (2002) Quality control methods of Medicinal Plant Materials.

WHO. Page.46.

132. J.B. Harbone (1984) Phytochemical Methods, A Guide to Modern

Tedhnique of Plant Analysis. Page. 4-8.

133. Handa SS, Khanuja SPS, Longo G, Rakesh DD. (2008) Extraction

Technologies for Medicinal and Aromatic Plants. International centre for

science and high technology, Trieste, Page. 21-25.

134. Kokate.C.K, (1994) Practical pharmacognosy,7th edition ; Vallabh

Prakashan; Page. 112.

135. Roopashree TS, Dang R, Rani SRH, Narendra C. (2008) Antibacterial

activity of anti-psoriatic herbs: Cassia tora, Momordica charantia and

Calendula officinalis. International Journal of Applied Research in Natural

Products, 1(3): 20-28.

136. Obasi NL, Egbuonu ACC, Ukoha PO, Ejikeme PM. (2010) Comparative

phytochemical and antimicrobial 25. screening of some solvent extracts of

Samanea saman pods. African journal of pure and applied chemistry,

4(9): 206- 212.

137. Audu SA, Mohammed I, Kaita HA. (2007) Phytochemical screening of the

leaves of Lophira lanceolata (Ochanaceae). Life Science Journal, 4(4):

75-79.

241

241

138. P.D.Sethi (1996) High Performance Thin Layer Chromatography 2nd

edition. Page.3-26.

139. Merlin NJ, Parthasarathy V, Manavalan R, Kumaravel S, (2009)Chemical

Investigation of Aerial Parts of Gmelina asiatica Linn by GC-MS.

Pharmacognosy Research. 1(3): 152- 156.

140. S. Gopala Krishnan, E Vadivel. (2011) GC-MS Analysis of some bio

active constituents of Mussaeanda frontosa Linn. International Journal of

Pharma and biosciences,2(1):313-320.

141. Raymond G. Reid, Satyajit Srkar. (2012) Isolation of Natural products by

Low Pressure, Column Chromatography: Natural Products isolation,

Springer Protocol. Page 155-187.

142. Richard J P Cannel. (1998). Natural Products isolation. Hermane Press,

New Jersy. Page. 111-112.

143. Robert M Silverstein, Francis X Webster. (2011) Spectrometric

idendification of Organic compounds, 6thedition, Wiley India.Page2-249.

144. Kemp W, (1991) Organic Spectroscopy. MacMillan Press Ltd,

London.Page 1- 416.

145. Sethi PD.(2008) Quantitative analysis of drugs in pharmaceutical

formulations. CBS Publishers, Delhi. Page. 1-643.

146. Avanappa Srrinivasa Rao, Namburi Baghya Lakshmi. (2014)

Pharmacological Screening methods and toxicology. Pharma med Press

Hyderabad. Page. 277- 279.

147. Asare GA, Addo P, Bugyei K, Gyan B, Adjei S, Otu-Nyarko LS, Wiredu

EK, Nyarko A. (2011) Acute toxicity studies of aqueous leaf extract of

Phyllanthus niruri; Interdisciplinary Toxicology. 4(4):206-210.

242

242

148. Harsh Mohan. (2010) Text Book of Pathology, sixth edition, Jaypee

brothers medical publishers. Page. 393-395.

149. Vogel H G and Vogel W H. (1997) Drug Discovery and Evaluation

Pharmacological assays, Springer Verlag, Berlin, Page.598.

150. Miller G J and Miller N E. (1975) Plasma- HDL Concentration and

development of Ischaemic Heart Disease. Lancet. 1:16-19.

151. Gotto AM Jr, LaRosa JC, Hunninghake D. (1990) The cholesterol facts. A

summary of the evidence relating dietary facts, serum cholesterol and

coronary heart disease, Circulation .81:1721-1733.

152. Buchwald H, Varco RL, Matts JP. (1990) Effect of partial ileal bypass on

mortality and morbidity from coronary heart disease in patients with

hypercholesterolemia report of the program on the Surgical Control of

Hyperlipidaemias. New England. Journal of Medicine. 323: 946-55.

153. Hossam M.M. Arafa. (2005) Curcumin attenuates dietinduced

hypercholesterem-ia in rats. Medical Science Monitoring.11(7): 228-234.

154. Jain G.C, S. Jhalani, S. Agarwal and K. Jain. (2007) Hypolipidemic and A

ntiatherosclerotic Effect of Leptadenia pyrotechnica Extract in Cholesterol

Fed Rabbits Asian Journal of Experimental. Science. 21(1) 115-122.

155. Metwally, M.A.A ,A.M. El-Gellal and S.M. El Sawaisi. (2009) Effects of

Silymarin on Lipid Metabolism in Rats. World Applied Sciences Journal 6

(12): 1634-1637.

156. Dubey Sonal and Pande V.V. (2008) Antihyperlipidemic activity of

Sphaeranthus indicus on Atherogenic diet induced hyperlipidemia in rats,

International journal of green pharmacy. 2(8):208.

243

243

157. Oliver Bever B.(1986) Oral hypoglycemic action of medicinal plants in

tropical West Africa. Cambridge University Press, London. Page 245-267.

158. Rai MK. (1995)A review on some antidiabetic plants of India. Ancient

Science of Life, 14, Page. 42-54.

159. Sarti C, Gallagher J. (2006) The metabolic syndrome: prevalence, CHD

risk, and treatment. Journal of Diabetes Complications, 20: 121-132.

160. Scheen, JA. (1990) Drug treatment of non-insulin dependent diabetes

mellitus in the 1990s. Achievement and future development drugs, 54:

355-368.

161. Shukla R, Sharma SB, Puri D, Pabhu KM, Murthy PS. (2006) Medicinal

plants for treatment of diabetes mellitus. Indian Journal of. Clinical.

Biochemistry. 156: 169-177.